| Literature DB >> 34937719 |
Luiz Eduardo Lima Andrade1, Beatriz Souza de Albuquerque Cacique New York2, Rafaella Silva Dos Santos Aguiar Gonçalves2, Sabrina Gabrielle Gomes Fernandes2, Álvaro Campos Cavalcanti Maciel2.
Abstract
OBJECTIVE: To map in the current literature instruments for the assessment and stratification of frailty in community-dwelling older people, as well as to analyse them from the perspective of the Brazilian context.Entities:
Keywords: epidemiology; geriatric medicine; public health
Mesh:
Year: 2021 PMID: 34937719 PMCID: PMC8704957 DOI: 10.1136/bmjopen-2021-052301
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Database search strategy
| Search | Query |
| #1 | (frail OR frailty) |
| #2 | (aging OR elderly) |
| #3 | (“independent living” OR “community dwelling”) |
| #4 | (“Observational Study”) |
| #5 | #1 AND #2 AND #3 AND #4 |
| Limit | There was no restriction on language and date of publication, only the study design that was delimited by the choice of the comparator #4 |
Details of the studies included according to the author, study design, sample size, instrument for assessing frailty and the prevalence of frailty in the older people.
| Author (year) | Study design | Sample size | Frailty assessment tool |
| Maltais | Prospective cohort | 113 older people of both sexes (≥70 years) | Phenotype of frailty |
| Serra-Prat | Cross-sectional | 324 older people of both sexes (≥75 years) | Phenotype of frailty |
| Tamaki | Cross-sectional | 800 older people of both sexes (≥65 years) | KC e Phenotype of frailty |
| Iizaka | Cross-sectional | 128 older people of both sexes (≥65 years) | Phenotype of frailty |
| Li | Prospective cohort | 2438 older people of both sexes (≥65 years) | Modified Phenotype of frailty |
| Zylberglait Lisiguerski | Prospective cohort | 291 older people of both sexes (≥65 years) | 5-item FRAIL |
| Shimada | Cross-sectional | 4072 older people of both sexes (≥65 years) | Phenotype of frailty; NCGG-FAT |
| Sampaio | Cross-sectional | 211 older people women (≥60 years) | KC |
| Garre-Olmo | Prospective cohort | 875 older people of both sexes (≥74 years) | Disability-free frailty phenotype |
| Wang | Prospective cohort | 635 older people women aged between 70–79 years | Phenotype of frailty |
| Crow | Cross-sectional | 4984 older people of both sexes (≥60 years) | Phenotype of frailty |
| Hasegawa | Cross-sectional | 308 older people of both sexes (≥65 years) | KC |
| Satake | Prospective cohort | 5542 older people of both sexes (≥65 years) | KC |
| Ballew | Cross-sectional | 341 older people of both sexes (≥66 years) | Phenotype of frailty |
| Zaslavsky | Prospective cohort | 876 older people women (≥65 years) | Phenotype of frailty |
| Monin | Prospective cohort | 2524 older people of both sexes (≥65 years) | Phenotype of frailty |
| Espinoza and Hazuda | Cross-sectional | 394 older people of both sexes (65–80 years) | Phenotype of frailty |
| Drubbel | Cross-sectional | 1549 older people of both sexes (≥60 years) | GFI e FI |
| Yao | Prospective cohort | 94 older people of both sexes (≥70 years) | Phenotype of frailty |
| Kiely | Prospective cohort | 765 older people of both sexes (≥70 years) | Phenotype of frailty; SOF-Frailty Index |
| Chaves | Cross-sectional | 389 older people women (≥65 years) | Phenotype of frailty |
| Ožić | Prospective cohort | 410 older people of both sexes (75–95 years) | TFI |
| Potier | Prospective cohort | 82 older people of both sexes (≥70 years) | Phenotype of frailty |
| Belisário | Cross-sectional | 705 older people of both sexes (≥60 years) | Phenotype of frailty |
| Sousa-Santos | Cross-sectional | 1457 older people of both sexes (≥65 years) | pPhenotype of frailty |
| Hoeksema | Cross-sectional | 1325 older people of both sexes (≥75 years) | GFI |
| Turusheva | Prospective cohort | 611 older people of both sexes (≥65 years) | Cumulative model (Puts model); Steventik-Slaets model (using the GFI); Phenotype of frailty |
| Bastone | Cross-sectional | 26 older people of both sexes (≥65 years) | Phenotype of frailty |
| Ruiz-Arregui | Prospective cohort | 1124 older people of both sexes (≥70 years) | Phenotype of frailty |
| Giudici | Prospective cohort | 1679 older people of both sexes (≥70 years) | Phenotype of frailty |
| Lin | Prospective cohort | 72127 older people of both sexes (≥65 years) | KC |
| Yeap | Prospective cohort | 3447 older people men aged between 70 and 89 years | FRAIL Scale. |
| Xue | Prospective cohort | 420 older people women aged between 70–79 years | Phenotype of frailty |
| Min | Prospective cohort | 3207 older people of both sexes (≥65 years) | VES-13 |
| Pegorari | Cross-sectional | 51 older people of both sexes (≥65 years) | Phenotype of frailty |
| McHugh | Prospective cohort | 624 older people of both sexes (≥65 years) | Modified frailty phenotype |
| Tian | Cross-sectional | 1917 older people of both sexes (≥60 years) | Phenotype of frailty |
| Freitas and Soares | Cross-sectional | 2972 older people of both sexes (≥65 years) | CFVI-20 |
| Fhon | Cross-sectional | 240 older people of both sexes (≥60 years) | EFS |
| Ribeiro | Methodological study | 396 older people of both sexes (≥60 years) | CFVI-20 e EFS |
| Ribeiro | Retrospective cohort | 311 older people of both sexes (≥60 years) | CFVI-20 e EFS |
| Moraes | Cross-sectional | 397 older people of both sexes (≥60 years) | CFVI-20 e CGA |
| Ribeiro | Retrospective cohort | 950 older people of both sexes (≥60 years) | CFVI-20 |
| Marques | Cross-sectional | 72 older people of both sexes (≥60 years) | TFI |
| Fabrício-Wehbe | Prospective cohort | 723 older people of both sexes (≥60 years) | EFS |
| Santiago | Cross-sectional | 219 older people of both sexes (≥60 years) | TFI and the brazilian version of TFI |
| Faller | Cross-sectional | 555 older people of both sexes (≥60 years) | Modified frailty phenotype e CFVI-20 |
| Neto | Cross-sectional | 196 older people of both sexes (≥60 years) | VES-13 |
| Balbinot and Uscocovich | Prospective cohort | 403 older people of both sexes (≥60 years) | VES-13 |
| Maia | Prospective cohort | 2143 older people of both sexes (≥60 years) | VES-13 |
| Barbosa | Cross-sectional | 368 older people of both sexes (≥60 years) | VES-13 e Social Vulnerability Index |
| Lang | Cross-sectional | 4818 older people of both sexes (≥65 years) | FI |
| Daniels | Prospective cohort | 430 older people of both sexes (≥70 years) | GFI; Dutch TFI; SPQ |
| Fukutomi | Prospective cohort | 883 older people of both sexes (≥65 years) | KC |
| Yamaguchi | Cross-sectional | 8174 older people of both sexes (≥65 years) | KC |
CFVI-20, Functional Clinical Vulnerability Index-20; CGA, Comprehensive Geriatric Assessment; EFS, Edmonton Frailty Scale; FI, Frailty Index; GFI, Groningen Frailty Indicator; KC, Kihon Check list; NCGG-FAT, National Center for Geriatrics and Gerontology-Functional Assessment Tool; SOF-Frailty Index, Frailty Index of Study of Osteoporotic Fractures; SPQ, Sherbrooke Postal Questionnaire; TFI, Tilburg Frailty Indicator; VES-13, Vulnerable Elders Survey.
Figure 1Selection diagram of studies involving instruments for screening and stratifying frailty in the older people.
Description of evaluation of frailty instruments (criteria evaluation and stratification)
| Evaluation of frailty instrument | Type of evaluation | Components | Score and stratification | Validated in Brazil | Prevalence of frailty among studies (%) |
| 5-item FRAIL | Subjective | 5 sections (fatigue, resistance, ambulation, illnesses and loss of weight) | Score: 0–5; Stratification: 0: robust, 1–2: prefrail, ≥3: frail | No | 16.8 |
| Clinical-Functional Vulnerability Index-20 | Subjective | 20 items, 8 sections (age, health self-perception, functional disabilities, cognition, mood, mobility, communication and presence of multiple comorbidities). | Score: 0–40; Stratification: 0–6: robust, 7–14: at risk of frailty, ≥15: frail | Yes | 12.60–21.79 |
| Comprehensive Geriatric Assessment | Mixed | Global functionality, functional systems ‘cognition, mood, mobility, and communication’, major physiological systems, medication use, past history and contextual factors ‘socio-family, environmental and caregiver assessment’ | Score: none; Stratification: classifies the subject in one of the 10 clinical-functional strata ≥4: frail | Yes | – |
| Disability-free frailty phenotype | Subjective | Physical frailty ‘chronic diseases, balance, nutrition, continence, vision, use of medicines, use of vasoactive drugs’, mental frailty ‘cognition, depression, cognitive self-concept, and quality of life’, and social frailty ‘living alone, lack of person to assist in activities of daily living, little contact with family, friends and neighbors, absence of a confidant, lack of support for activities for 3 months’ | Score: none; Stratification: >4: physical frailty, >2: mental frailty, >2: social frailty | No | Physical frailty: 17.3 |
| Edmonton Frail Scale | Mixed | 11 items, 9 sections (cognition, general health state, functional independence, emotional support, medication use, nutrition, mood, continence, and functional performance). | Score: 0–17; Stratification: 0–4: no frailty, 5–6: apparently vulnerable, 7–8: mild frailty, 9–10: moderate frailty, >11: severe frailty | Yes | Mild frailty: 16.7–18.3 |
| FRAIL Scale | Subjective | 5 items (fatigue, resistance ‘ability to climb up one flight of stairs’, ambulation ‘ability to walk one block’, illness ‘>5 comorbidities’, and loss of weight ‘>5%’) | Score: 0–5; Stratification: 0: robust, 1–2: prefrail, >3: frail | No | 15.3 |
| Frailty Index | Subjective | 36 items (selected from the ICPC-coded, includes symptoms, diseases, functional impairments and social problems). | Score: ratio between deficits present within the total of 36 deficits. (Cut-off 0,08); Stratification: >0,08 Frail, <0.08 robust | Yes | Frailty: 60 |
| Groningen Frailty Indicator | Subjective | 15 items (physical, cognitive, social and psychological functionality) | Score: 0–15; Stratification: 0–3: robust, >4: frail | Yes | 22–46 |
| Modified Frailty Phenotype | Objective | Handgrip strength, walking speed, unintentional weight loss and fatigue | Score: 0–4; Stratification: 0: robust, 1: prefrail, >2: frail | Yes | 8.98–37.10 |
| NCGG-FAT | Subjective | Memory, attention, executive function and processing speed | Score: 0–10; Stratification: >2: frailty cognitive (indicated by the age-compatible score (1.5 SD below the reference value) | No | 5.2 |
| Phenotype of frailty | Mixed | Handgrip strength, gait speed, unintentional weight loss, fatigue and physical activity level | Score: 0–5; Stratification: 0: robust, 1–2: prefrail, ≥3: frail | Yes | 3–35 |
| Sherbrooke Postal Questionnaire | Subjective (questionnaire) | 6 items (physical, social, and cognitive domains of functioning) | Score: 0–6; Stratification: >2: frail | No | 58.1 |
| Study of Osteoporotic Fractures Frailty Index | Mixed (physical performance evaluation and questionnaire) | Unintentional weight loss, inability to rise from a chair 5 times without the use of arms, and reduced energy level | Score: 0–3; Stratification: 0: robust, 1: prefrail, 2–3: frail | No | 4.18 |
| The cumulative deficit approach (Puts model) | Mixed (multidimensional) | Body weight, peak expiratory flow, cognition, presence of a vision problem a hearing problem or urinary incontinence—low mastery, depressive symptoms, and comorbidity | Score: None*; Stratification: 0: robust, 1–2: prefrail, >3: frail | No | 38.5 |
| The Kihon Checklist | Subjective (questionnaire) | 25 items (activities of daily living ‘basic and social’, exercise, falls, nutrition, oral function, cognitive function and depression) | Score: 0–25; Stratification: 0–3: robust, 4–7: prefrail, 8–25: frail | Yes | 7–17.2 |
| Tilburg Frailty Indicator | Subjective (questionnaire) | 25 items (determinants of frailty and diseases and components of frailty in three domains ‘physical, psychologic and social frailty’) | Score: 0–15; Stratification: 0–4: robust, >5: frail | Yes | 27.10–45.83 |
| Vulnerable Elders Survey-13 | Subjective (questionnaire) | 13 items (age, self-reported health, functional capacity, and physical condition) | Score: 0–10; Stratification: ≤2: robust, 3–6: risk of frailty, ≥7: frail | Yes | 12–52.7 |
NCGG-FAT, National Center for Geriatrics and Gerontology-Functional Assessment Tool.